英科医疗(300677) - 英科医疗 调研活动信息

Company Overview - The chairman of Yingke Medical has over 30 years of industry experience and established the company in 2009, focusing on R&D and technology enhancement [3][4] - The company aims to become a leading high-tech enterprise in medical consumables and devices, leveraging its global marketing channels in over 120 countries [3][4] Production Capacity - As of June 2021, the annual production capacity reached 51 billion pieces, with 27 billion being nitrile gloves and 24 billion PVC gloves [4] - The company has expanded its production capacity significantly from 19 billion pieces at the end of 2019 to 36 billion pieces by the end of 2020 [4] Industry Landscape - The number of global glove manufacturers increased from 120-150 before the pandemic to over 300 during the pandemic, but many smaller firms are expected to exit the market as prices stabilize [5] - Post-pandemic, it is anticipated that only 10-30 manufacturers will remain, with leading companies covering over 80% of the global market [5] Competitive Advantages - Yingke Medical maintains competitive production efficiency and a larger talent pool compared to Malaysian competitors, which face challenges such as high worker infection rates during the pandemic [5][6] - The company benefits from lower raw material costs and a favorable tax rate of 15% compared to Malaysia's 24% [6] Marketing Strategy - The company has established marketing centers in the US, Canada, Germany, Hong Kong, and Singapore, with plans to expand further in the next 2-3 years [6] - It has served over 10,000 clients across more than 120 countries, with a healthy customer composition that includes both long-term and new clients [6] Domestic Market Insights - Prior to the pandemic, the average annual usage of medical gloves in China was only 6 pieces per person, which saw a significant increase during the pandemic [6] - Domestic sales accounted for over 20% of total sales, with some domestic products being exported [6]